HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RB Steps Up Investment In AI Symptom Checker

Executive Summary

Reckitt Benckiser is taking a larger slice of AI-powered symptom checker Your.MD as it invests in the future of digitally-enabled self-care globally.

You may also be interested in...



RB Coughs Up For Digital Diagnostic Development

Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.

Sanofi Tapping AI To Help Consumers Manage IBS

Sanofi is utilizing AI technology to help UK consumers to better manage their IBS and digestive symptoms. 

Reckitt Invests In AI Symptom Checker To 'Unlock Self-Care'

Reckitt Benckiser has invested in 'doctor in your pocket' app Your.MD in response to consumers increasing demand for digital healthcare. The app's AI-powered symptom checker claims to diagnose with high accuracy a range of medical conditions. 

Topics

Related Companies

UsernamePublicRestriction

Register

LL1122620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel